key: cord-0706315-9fhtwv8u
authors: Gregoire, Claude; Spinelli, Lionel; Villazala-Merino, Sergio; Gil, Laurine; Moussa, Myriam; Dong, Chuang; Zarubica, Ana; Fallet, Mathieu; Navarro, Jean-Marc; Malissen, Bernard; Milpied, Pierre; Gaya, Mauro
title: Viral infection engenders bona fide and bystander lung memory B cell subsets through permissive selection
date: 2021-12-15
journal: bioRxiv
DOI: 10.1101/2021.12.14.472614
sha: c1380a5b974d38f84d4a648807cf0ad9e4fb0f25
doc_id: 706315
cord_uid: 9fhtwv8u

Lung-resident memory B cells (MBCs) provide localized protection against reinfection in the respiratory airways. Currently, the biology of these cells remains largely unexplored. Here, we combined influenza and SARS-CoV-2 infection with fluorescent-reporter mice to identify MBCs regardless of antigen specificity. scRNA-seq analysis and confocal imaging revealed that two main transcriptionally distinct subsets of MBCs colonize the lung peribronchial niche after infection. These subsets arise from different progenitors and are both class-switched, somatically mutated and intrinsically biased in their differentiation fate towards plasma cells. Combined analysis of antigen-specificity and B cell receptor repertoire unveiled a highly permissive selection process that segregates these subsets into “bona fide” virus-specific MBCs and “bystander” MBCs with no apparent specificity for eliciting viruses. Thus, diverse transcriptional programs in MBCs are not linked to specific effector fates but rather to divergent strategies of the immune system to simultaneously provide rapid protection from reinfection while diversifying the initial B cell repertoire.

The immune system mounts protective responses to counteract the threat posed by pathogens during infection. These responses leave immunological memory, a strategy that allows our body to remember previously encountered pathogens. Memory B cells (MBCs) and T cells are long-lived lymphocytes that constitute an essential component of this strategy (Akkaya et al., 2020) . These cells take up residence in secondary lymphoid organs and remain in quiescent state until a secondary antigen encounter. Upon re-challenge, they rapidly produce large numbers of effector cells that deliver fast and effective protection (Weisel and Shlomchik, 2017) . In the case of MBCs, they can either differentiate into short-lived plasma cells, which produce high-affinity neutralizing antibodies, or re-enter germinal centers and provide, up to a certain extent, a new source of long-lasting protection with increased affinity and breadth McHeyzer-Williams et al., 2015; Mesin et al., 2020; Viant et al., 2020) . MBC fate decision can be shaped by cell-intrinsic features, B cell receptor isotype, antigen affinity and the magnitude of CD40 signalling (Dogan et al., 2009; Koike et al., 2019; Pape et al., 2011; Viant et al., 2020 Viant et al., , 2021 Zuccarino-Catania et al., 2014) .

Memory lymphocytes do not exclusively reside in secondary lymphoid organs. For instance, a lineage of T cells can occupy the tissue barriers after infection without recirculating. These tissue-resident memory T cells are transcriptionally and functionally distinct from recirculating ones, and provide site-specific responses against infection (Szabo et al., 2019) . Yet, if a B cell counterpart of these cells existed remained unknown. A recent study has shown, through the use of elegant parabiotic experiments, that a population of tissue-resident MBCs settle in the lungs after influenza virus infection (Allie et al., 2019) . Lung MBCs not only ensure a first layer of protection directly at the tissue barrier but also display high cross-reactivity to viral escapes, highlighting the potential of targeting them to develop broadly protective vaccines (Adachi et al., 2015; Onodera et al., 2012) . At present, it remains unknown if lung MBCs occupy specific tissue niches in the lung mucosa, if they bear special transcriptional programs that allow their survival in the lung airways or if discrete MBC subsets coexist upon infection.

Here, we combined the use of Aicda-Cre ERT2 Rosa26-EYFP reporter mice with influenza and SARS-CoV-2 infection models to track lung MBCs based on past Aicda expression at the time of viral infection. As this approach does not rely on the ability of MBCs to bind viral antigens, it gave us access to cells with little or no affinity for specific antigens, which can represent a large proportion of MBCs (Viant et al., 2020) and were disregarded in previous studies. We show, for the first time, that two main subsets of MBCs permanently colonize the lung peribronchial niche upon respiratory viral infection. These subsets arise from different progenitors that underwent class-switching and somatic hypermutation in germinal centers, and subsequently acquired divergent transcriptional programs and chemokine/Fc receptor patterns. Unexpectedly, both MBC subsets are intrinsically biased in their differentiation fate towards plasma cells, highlighting that divergent transcriptional programs are not associated with specific effector fates. Instead, these subsets segregate "bona fide" MBCs, which dominate recall responses by producing high affinity antibody-secreting cells, from "bystander" MBCs, with no specificity for the immunogen, unable to produce protective antibodies but with the ability to retain and display antigen in the form of immune complexes. These results challenge the notion that germinal centers only work as "machines" to produce high-affinity bona fide MBCs. Instead, permissive selection mechanisms simultaneously operate in these reactions, expanding the diversity of the initial B cell repertoire and giving rise to bystander MBCs.

In order to identify lung-homing MBCs without introducing a bias on antigen specificity, we took advantage of the Aicda-Cre ERT2 Rosa26-EYFP mouse strain, from now on referred as Aid-EYFP (Le Gallou et al., 2018) . This model allows us to permanently label cells that have expressed activation-induced cytidine deaminase, the enzyme that initiates class-switching and somatic hypermutation, at the time of tamoxifen treatment. As a vast fraction of MBCs have gone through at least one of these two processes early in the response to infection, we expect them to be labelled by tamoxifen. Accordingly, we intranasally infected Aid-EYFP mice with 5 plaque-forming units (PFUs) of influenza A virus Puerto Rico/8/34 (PR8) H1N1 strain, and orally administered tamoxifen at days 6, 8 and 10. We assessed the efficiency and specificity of this strategy after 10 weeks of infection by flow cytometry ( Figure 1A) . We observed the presence of a discrete population of YFP + cells in lungs and secondary lymphoid organs, mostly corresponding to CD19 + B cells and a small population of CD19plasma cells ( Figure 1B and Extended Figure 1A ). Strikingly, more than 90% of YFP + lung cells showed a phenotype associated with MBCs (CD38 + GL-7 -) ( Figure 1C ). In contrast, only 30% of YFP + lymph node cells showed a MBC phenotype; the great majority were still committed to long-lived germinal centers (CD38 -GL-7 + ) that persist in mediastinal lymph nodes long after viral clearance ( Figure 1C ).

To determine whether these YFP + cells are genuine MBCs, we measured antigen-specificity, class-switching, accessibility to blood circulation and lifespan. Regarding specificity, we detected an average of 30% of YFP + B cells binding to APC-labelled influenza nucleoprotein (NP) and an average of 5% that bound to PE-labelled influenza hemagglutinin (HA); less than 2% of YFP -B cells bound to these proteins ( Figure 1D and Extended Figure 1B ). These results indicate that the YFP + population is enriched in B cells specific for influenza antigens.

Regarding class-switching, we observed that YFP + cells lacked IgD expression while YFPcells were mainly IgD + , showing that YFP + cells have undergone extensive class-switching ( Figure 1E ). To measure accessibility to blood, we administered fluorescently labelled anti-CD45 antibody intravenously 5 minutes before sacrifice.

We found that more than 95% of lung YFP + cells, in marked contrast to YFP -B cells, were protected from in vivo antibody labelling, indicating that these cells preferentially accumulate in the lung parenchyma rather than in the blood circulation ( Figure 1F ). In mediastinal lymph nodes and spleen, both YFP + and YFPwere mostly protected from in vivo antibody labelling, in line with the notion that B cells residing in lymphoid organs are not in direct contact with the blood circulation ( Figure 1F ). As expected, only spleen marginal zone B cells were labelled by anti-CD45 (Figures 1F and Extended Figure 1C ). We finally enumerated YFP + cells in lungs, mediastinal lymph node and spleen at different time points after infection to get an insight into the lifespan of these cells. We found that the kinetics of YFP + cells follow a similar trend across organs: YFP + cells were detected at low numbers at day 12, peaked between days 20-30 and slowly declined thereafter ( Figure 1G ).

Remarkably, YFP + B cells were detected in significant numbers even one year after infection, suggesting that these cells are long-lived ( Figure 1G ). The accumulation of YFP + B cells in lungs was not observed in mice administered with UV-inactivated influenza virus, pointing out that infection, or the inflammation process associated with it, is required for the establishment of MBCs ( Figure 1H ). Altogether, these results highlight the power of our strategy to track long-lived class-switched MBCs homing to the lungs and lymphoid organs without introducing a bias on antigen specificity.

To unveil if influenza infection engenders discrete subsets of MBCs in lungs and draining lymphoid organs, we performed scRNA-seq on YFP + CD19 + CD38 + GL-7 -MBCs sorted from lungs, mediastinal lymph nodes and spleen at day 70 after influenza infection. After tagging cells with mouse-and organ-specific hashtag antibodies, we captured single cells from three mice using the droplet-based microfluidic system Chromium (10X) and performed 5'-end scRNA-seq and scBCR-seq. After processing and filtering (see Methods), we retained 4,679 good quality cells for subsequent analysis: lung n=2,041; lymph node n=521; spleen n=2,117.

We performed Uniform Manifold Approximation and Projection (UMAP) for dimensionality reduction within each tissue and found that MBCs bifurcated into three separate clusters within lungs and mediastinal lymph nodes and into five clusters in spleen (Figures 2A-2D ). By analyzing gene expression, we identified groups of marker genes associated with specific B cell clusters, reflecting divergent transcriptional programs within these memory populations (Figures 2E) . To compare the extent of similarity across lung MBC clusters with those from draining lymphoid organs, we calculated the Szymkiewicz Simpson similarity index. We found that lung clusters Lg1, Lg2 and Lg3 shared high levels of marker genes' overlap with lymph node clusters Ln1, Ln2 and Ln3 respectively, indicating shared memory mechanisms operating across these organs ( Figure 2F ). In contrast, the spleen contained specific MBC populations, such as Sp4 and Sp5, that were absent in lungs ( Figure 2F ). These data show that the MBC pool is not homogeneous but, instead, is constituted of transcriptionally distinct subpopulations that are either tissue-specific or shared across organs.

Among MBCs residing in lungs and lymph nodes, those belonging to the two major clusters (Lg1-Ln1 and Lg2-Ln2) expressed the chemokine receptor Ccr6 while most cells from the minor cluster (Lg3-Ln3) did not (Figures 2A, 2B and 2E) . Out of the top differentially expressed genes, we found that: Cluster 1 (Lg1-Ln1) cells expressed the IgE Fc receptor Fcer2a (CD23), the calcium-binding protein Cnn3, and the cysteine-rich protein Lmo2; Cluster 2 (Lg2-Ln2) cells expressed the chemokine receptor Cxcr3, the placenta-specific protein Plac8, the cystatin Cst3 and the integrin Itga4; Cluster 3 (Lg3-Ln3) cells expressed the membrane-spanning 4-domains Ms4a6c, the transcription factor Nfatc1, and the zinc finger and BTB domain-containing protein Zbtb32 (Figures 2A, 2B and 2E ). Importantly, we were able to distinguish previously unreported populations of MBCs in lungs and lymph nodes by flow cytometry using the cluster-identifying markers Ccr6 and Cxcr3: Ccr6 + Cxcr3 + , Ccr6 + Cxcr3and Ccr6 -Cxcr3 - (Figures 2G-2H ).

In spleen, MBCs from the major cluster Sp1 expressed Ccr6, Lmo2, Fcer2a and Cxcr3, a gene expression pattern associated with follicular MBCs (Figures 2C and 2E ). Cells from cluster Sp2 were characterized by high levels of the Krüppel-like factor Klf2, the complement decay-accelerating factor Cd55, and the cytoskeletal protein Vimentin Vim, resembling transitional MBCs ( Figures 2C and 2E ). Cells from cluster Sp3 expressed the tyrosine kinase Lck, Nfatc1, Ms4a6c, and Zbtb32, a similar gene pattern to the one observed in B1 cells (Figures 2C and 2E) . Cells from cluster Sp4 expressed high levels of the complement receptor Cr2 (CD21) and the sphingosine 1-phosphate receptors S1pr1 and S1pr3, resembling marginal zone MBCs ( Figures 2C and 2E ).

Lastly, cells from the smallest cluster Sp5 expressed the transcription factor Tbx21 (T-bet) and the integrin Itgax (Cd11c), resembling age-associated MBCs (Figures 2C and 2E) (Riedel et al., 2020) . Notably, we could segregate follicular, transitional, B1-like, marginal zone and age-associated MBCs by flow cytometry based on the expression of the representative surface markers CD11c, Ccr6, CD21, CD55 and CD24 ( Figure 2I ). This data is in line with two potential scenarios: i) splenic B cells with diverse origins and developmental stages participate in the memory response to influenza infection; ii) MBCs acquire distinct phenotypes upon exiting germinal centers due to environmental factors. Subsequent B cell receptor (BCR) analysis presented in Figure   4 is consistent with the first model.

It is relevant to report that in our initial analysis, we observed a fourth cluster of cells in the lungs with high expression of immediate-early response genes and heat-shock protein genes (Hspa1a, Hspa1b, Dnajb1, Jun) that was later removed for further analysis (Extended Figure 2A ). This gene signature has been previously reported in other cell types after tissue dissociation with collagenase at 37℃ (Adam et al., 2017; O'Flanagan et al., 2019) . To assess if the presence of this fourth cluster was due to the dissociation protocol, we repeated the scRNA-seq experiment; this time around we dissociated lungs mechanically at 4℃ rather than enzymatically.

Although the number of cells recovered was significantly lower, we observed that this "stressed" subpopulation disappeared, confirming the artifactual origin of this phenomenon (Extended Figure 2B ). Importantly, in this second data-set we were able to identify clusters of MBCs with gene expression patterns similar to the ones obtained in our first data-set, providing further evidence for intra and inter-organ heterogeneity of MBCs during viral infection (Extended Figures 2B-2D ).

Our single-cell RNA-seq and flow cytometry data revealed the co-existence of discrete subsets of MBCs in the lung mucosa. As these subsets expressed contrasting patterns of Ccr6 and Cxcr3 receptors, we wondered if they exhibit differential micro-anatomic distributions. To gain insight into their spatial positioning, we infected Aid-EYFP mice with influenza virus and harvested lungs after 70 days. We stained tissue sections with specific antibodies and analyzed them by confocal microscopy. We found that YFP + MBCs assembled in discrete B220 + clusters composed of hundreds of cells. These clusters were found in areas surrounding EpCAM + epithelial cells, indicating that MBCs preferentially locate in peribronchial areas ( Figure 3A ). We further extended the analysis to lymphoid organs by tracking YFP + cells devoid of germinal center (GL-7) and plasma cell (CD138) markers. In lymph nodes, MBCs preferentially accumulated in follicles and interfollicular areas but rarely in the paracortex or medulla. Strikingly, a third of follicular MBCs were found within a 10μm distance from the subcapsular sinus ( Figure 3B ). In spleen, YFP + MBCs were mostly found in follicles, in close association with the marginal zone ( Figure 3C ). Altogether, these results show that MBCs remain positioned at sites of antigen entry after resolution of infection, a strategy that facilitates a fast encounter of pathogens upon re-challenge.

To visualize individual MBC subsets in the lungs, we stained tissue sections with antibodies against YFP, B220, Ccr6 and Cxcr3. We observed a wide range of Ccr6 and Cxcr3 expression among YFP + cells ( Figure 3D ). We then generated a mask on YFP + cells, excluded plasma cells based on their size and B220 expression, and measured Ccr6 and Cxcr3 fluorescence on individual YFP + cells. By plotting Cxcr3 versus Ccr6 fluorescence intensity, we observed a cell distribution pattern that closely resembled the one obtained by flow cytometry (Figures 2G and 3E) . Interestingly, when we tracked each subset back into space, we found that cells from the two main Ccr6 + subsets localized in the center of B cell clusters while cells lacking Ccr6 were excluded to the peripheral areas ( Figure 3E ). Due to this marked differential positioning, we investigated if Ccr6 was required by MBCs to access peribronchial B cell clusters. To this end, we generated Aid-EYFP mice lacking Ccr6 expression, infected them with influenza virus and analyzed lung sections at day 70 of infection. We found similar numbers of YFP + MBCs within B cell clusters in wild type and Ccr6-deficient mice, indicating that Ccr6, per se, is dispensable to enter the peribronchial niche ( Figure 3F ). Altogether, our analysis revealed a new layer of organization at the core of peribronchial B cell clusters, with MBCs segregating into discrete regions.

To further test if Ccr6 and Cxcr3 chemokine receptors play a role in the retention of MBCs in the lung mucosa or lymphoid organs, we generated chimeric mice by lethally irradiating µMT animals and injecting a mixture of 80% µMT bone marrow and 20% of either wild type, Ccr6-or Cxcr3-deficient bone marrow ( Figure 3G ). As µMT mice lack mature B cells, chemokine-knockout chimeras harbored Ccr6 or Cxcr3-deficient B cells in an environment consisting of mostly wild type cells ( Figures 3H-3I ). After 8 weeks of reconstitution, we infected chimeric mice with 5 PFU of H1N1 PR8 influenza virus and sacrificed them 70 days after for analysis. Surprisingly, we observed comparable numbers of CD19 + IgD -CD38 + GL-7 -MBCs among wild type, Ccr6 and Cxcr3-deficient chimeras, indicating that these receptors are dispensable for MBC maintenance ( Figures   3J-3K ). We then assessed if Ccr6 and Cxcr3 are required for the memory response during secondary influenza infection. To test this, we infected chimeric mice with influenza virus H1N1 PR8 and after 70 days we challenged them with 5.10 4 PFU of influenza H3N2 X31 strain. Four days after re-infection, we measured the formation of IgM, IgG and IgA NP-specific antibody-secreting cells (ASCs) by ELISpot. We observed a 10-fold decrease in the formation of IgA ASCs in Ccr6-deficient chimeras compared to wild type counterparts, while the numbers of IgM and IgG ASCs were similar among both groups ( Figure 3L ). This defect was observed in lungs, lymph nodes and spleen, suggesting a general mechanism for Ccr6 in IgA responses across organs. In contrast, we observed comparable numbers of ASCs in wild type and Cxcr3-deficient chimeras, indicating that Cxcr3 is dispensable for memory responses during influenza infection ( Figure 3M ). Overall, our results show that Ccr6, but not Cxcr3, is required for recall of humoral responses to influenza virus.

Having shown that discrete subsets of MBCs with divergent transcriptional programs and tissue distribution co-exist upon resolution of influenza infection, we sought to investigate if the subsets arise from common or distinct progenitors. To achieve this, we produced and sequenced single-cell BCR-seq libraries from the same cells analyzed by droplet-based scRNA-seq. Analysis of the constant heavy chain (IgH) revealed that MBCs residing in lungs and lymph nodes displayed extensive class-switching towards IgG isotypes, such as IgG1, IgG2b and IgG2c, while the majority of splenic memory cells expressed IgM ( Figure 4A ). To assess if this difference was due to the presence of different B cell subpopulations across organs, we analyzed isotype expression individually in each cell cluster. In lungs and lymph nodes, the two major Ccr6 + clusters (Lg1-Ln1 and Lg2-Ln2) showed considerable class-switching towards IgG isotypes while the minor Ccr6cluster (Lg3-Ln3) was almost exclusively composed of IgM + cells ( Figure 4B ). In spleen, the major follicular MBC cluster (Sp1) exhibited substantial class switching towards IgG isotypes while transitional (Sp2), B1-like (Sp3), marginal zone (Sp4) and ABC (Sp5) MBCs were mainly IgM + ( Figure 4B ). Concerning the constant light chain, we observed that Kappa (IgK) was the most commonly expressed among MBCs regardless of the cell cluster and organ of origin ( Figure 4C ). Yet, we found unusual high numbers of Lamba + cells in the minor IgM + Ccr6cluster (Lg3-Ln3) from lungs/lymph nodes and in transitional (Sp2) and B1-like (Sp3) MBCs from spleen ( Figure   4C ). Altogether, these results unveiled that the MBC pool displays pronounced intra-and inter-organ differences on isotype-class usage.

The marked heterogeneity on isotype-classes led us to investigate the magnitude of BCR diversification driven by the differential use of variable genes (IgHV, IgKV and IgLV) and the length of the complementarydetermining region 3 (CDR3) within each subset. We observed that the two major class-switched Ccr6 + clusters (Lg1-Ln1 and Lg2-Ln2) in lungs/lymph nodes and the follicular (Sp1), marginal zone (Sp4) and ABC (Sp5) clusters in spleen, displayed high usage of the IgHV1, 5, 9, 14 and IgKV5, 6 families ( Figures 4D and 4E ).

By contrast, the minor IgM + Ccr6clusters (Lg3-Ln3) from lungs/lymph nodes and the transitional (Sp2) and B1-like (Sp3) clusters from spleen showed a completely different pattern of expression: high usage of IgHV1, 4, 6; IgKV1, 2, 4, 8, 14 and IgLV1 (Figures 4D and 4E) . Remarkably, these clusters further exhibited a significantly lower length of the IgH CDR3 when compared to clusters from the same organ ( Figure 4F ). These results demonstrate that MBC subsets are skewed towards divergent families of variable genes, in line with the notion that certain memory subsets may originate from different naïve precursors. To further test this idea, we defined clonotypes and measured clonal overlaps in MBC clusters. We detected significant overlap of clonal BCR repertoires among lung/lymph node clusters containing class-switched Ccr6 + cells and the splenic follicular cluster, Lg1-Ln1-Sp1 on one side and Lg2-Ln2-Sp1 on the other side ( Figure 4G ). We further detected high levels of clonal overlap among the lung/lymph node clusters enriched in IgM + Ccr6cells and splenic transitional and B1-like clusters (Lg3-Ln3-Sp2-Sp3) ( Figure 4G ). These results imply that certain memory populations are interconnected in their generation and/or maintenance across organs. Remarkably, hierarchical clustering showed that the minor "innate-like" group of IgM + Ccr6cells represented a separate lineage from class-switched Ccr6 + MBCs, providing further evidence that these populations emerge from different progenitors ( Figure 4G ).

The two major class-switched Ccr6 + memory populations identified in lungs and draining lymph nodes, display divergent transcriptional programs and can be segregated based on their Cxcr3 expression ( Figure 2 ). To evaluate whether these two subsets were both product of germinal center reactions, we infected two groups of Aid-EYFP mice with influenza virus H1N1 and between days 6-10 we administered tamoxifen with either blocking anti-CD40L antibody or isotype control. By using this window of time, we allow early B-T cell contacts while targeting subsequent B-T follicular Helper cell interactions in germinal centers. We observed a dramatic reduction of YFP + germinal center cells in mice treated with anti-CD40L antibody compared to control animals ( Figure 4H ). Importantly, we found that the Cxcr3and the Cxcr3 + subsets were markedly reduced in mice receiving anti-CD40L treatment, strongly suggesting that both MBC subsets are products of germinal centers ( Figure 4I ). We then measured if these two populations arose from B cell precursors that played an active role in germinal center reactions. To assess this, we measured the average rate of somatic hypermutation (SHM) in IgHV and IgKV genes in our two scRNA-seq datasets. We found that the Lg1 cluster (Cxcr3 low) displayed significantly higher average levels of SHM in the IgHV and IgKV genes than the Lg2 cluster (Cxcr3 high) ( Figures 4J and 4K ). When analyzing SHM in individual cells, we found that the Lg1 cluster (Cxcr3 low) is enriched in cells with high levels of mutations while the Lg2 cluster (Cxcr3 high) is enriched in cells with lower SHM levels ( Figures 4J and 4K ). These results indicate that the two major Ccr6 + class-switched MBC subsets derived from cells that underwent SHM in germinal centers, but either at dissimilar rates or for different periods of time.

We wondered whether these two transcriptionally distinct subsets of class-switched Ccr6 + MBCs were intrinsically biased in their differentiation fate towards plasma versus germinal center cells upon re-activation.

To evaluate this, we sorted Ccr6 + Cxcr3and Ccr6 + Cxcr3 + MBC subsets from lungs and lymph node at day 70 after influenza infection and cultured them ex vivo in the presence of 40LB feeder cells, sources of BAFF and CD40-L, plus IL-21 for 3 days ( Figure 5A ) (Nojima et al., 2011) . Under these conditions, MBCs have been shown to differentiate into plasma or germinal center cells according to cell intrinsic features (Koike et al., 2019) . Flow cytometry analysis revealed that both Ccr6 + MBC subsets mostly differentiated into CD93 + plasma cells and rarely into GL-7 + germinal center B cells, regardless of their Cxcr3 expression or organ of origin ( Figures 5B-5C ). Furthermore, we detected similar IgG levels across samples, indicating that these cells produce antibodies to the same extent ( Figure 5D ). Unexpectedly, we found that plasma cells derived from Cxcr3 + MBCs produced high levels of antibodies specific for influenza NP and HA while plasma cells derived from Cxcr3 -MBCs produced low to undetectable levels of NP and HA-specific antibodies ( Figure 5E ). These results demonstrate that Cxcr3and Cxcr3 + MBC subsets are both intrinsically predisposed towards the plasma cell program but show profound differences in their ability to produce virus-specific antibodies upon activation. We then examined the specificity of MBC subsets for influenza antigens. To this end, we incubated lung and lymph node cell suspensions from influenza infected mice (day 70) with fluorescently labelled NP and HA. Flow cytometry analysis revealed that Cxcr3 + MBCs bound extensively to influenza antigens while Cxcr3cells showed minimal binding (Figures 5F-5G). Thus, the Cxcr3 + MBC subset is indeed enriched in antigen specific cells while the Cxcr3subset comprises cells with no apparent specificity for influenza proteins.

These unforeseen results led us to investigate the involvement of these two MBC subsets in homotypic and heterosubtypic immunity to influenza infection. For the former, we took advantage of a previously described in vivo set-up (Onodera et al., 2012) . We i.v. transferred naive splenocytes to µMT mice and treated them intranasally with CpG to generate bronchoalveolar lymphoid structures. After ten days, we transferred Cxcr3or Cxcr3 + MBCs sorted from lungs of previously PR8-infected animals together with splenic CD4 + T cells isolated from the same donors. We intranasally infected these animals with influenza PR8, monitored weight daily and euthanized those mice exhibiting ≥20% loss of initial mass ( Figure 5H ). We observed that mice receiving Cxcr3 + MBCs were highly protected from influenza infection while more than 50% of those receiving Cxcr3 -MBCs needed to be euthanized between day 6 and 8 ( Figure 5H ). Therefore, Cxcr3 + and Cxcr3subsets differ in their ability to provide homotypic protection. To investigate the ability of these subsets to intrinsically respond to re-infection with a different influenza serotype, we intranasally treated Aid-EYFP mice with PBS or influenza PR8 and gave them tamoxifen from days 6-10. At day 70, we intranasally challenged these mice with either PBS or influenza X31 and sacrificed them after 4 days. Secondary infection with X31 led to robust formation of flu-specific antibody-secreting cells ( Figure 5I ). These cells were mainly derived from lung MBCs, as this response was not observed in mice receiving PR8 or X31 infection alone ( Figure 5I ). Taking this into account, if one subset of MBCs is preferentially engaged into secondary responses, we should observe a change in subsets ratio before and after re-challenge (Allie et al., 2019) . We found that the Cxcr3 + /Cxcr3memory ratio is close to 2 after primary infection (PR8 alone) ( Figure 5J ). Interestingly, we observed a significant and marked decrease in the Cxcr3 + /Cxcr3ratio upon secondary infection (PR8 + X31), indicating that Cxcr3 + MBCs were actively differentiating into effector cells when compared to the Cxcr3subset ( Figure   5J ). Altogether, these results show that influenza infection gives rise to two distinct populations of Ccr6 + MBCs in lungs: i) a Cxcr3 + subset enriched in MBCs with specificity for influenza antigens that robustly respond upon secondary challenge by secreting protective antibodies, and ii) a Cxcr3subset enriched in MBCs with no evident specificity for influenza antigens and restricted effector capacity in recall responses.

We were intrigued by the results showing that the Ccr6 + Cxcr3 -MBC subset is composed of cells that underwent class-switching and somatic hypermutation but do not display evident specificity for influenza antigens. This led us to consider three hypotheses regarding their origin: i) these cells are low-affinity MBCs with undetectable antigen capture in our flow cytometry antigen-binding assay, ii) these cells were initially antigen-specific but subsequently acquired disadvantageous mutations and escaped germinal center reactions as non-specific MBCs, iii) these are non antigen-specific cells that were selected in germinal centers through alternative permissive mechanisms. While in the first two scenarios Cxcr3 -MBCs can share progenitors with antigen-binding cells, no clonal overlap is expected in the third possibility. To discern among these contrasting situations, we performed single-cell index sorting of lung YFP + MBCs from 3 mice at day 70 of influenza infection. For each cell, we recorded the information of NP/HA antigen-binding and the expression levels of surface Ccr6/Cxcr3 receptors. We then performed FACS-Based 5-Prime End (FB5P) single-cell RNA-seq on sorted cells for the integrative analysis of transcriptome and BCR repertoire (Attaf et al., 2020) . After processing and filtering, we retained 983 good quality cells with information on heavy and light chains for subsequent analysis. In this dataset, most cells that bound NP/HA antigens were part of the Ccr6 + Cxcr3 + subset, reinforcing our previous results ( Figure 6A ). We further measured the expression of cluster-identifying genes from our first scRNA-seq datasets in the different MBC subsets ( Figure 2E and 6B). We found that the Ccr6 + Cxcr3subset express high levels of Lg1 cluster genes (Fcer2a, Cnn3, Lmo2), the Ccr6 + Cxcr3 + subset express high levels of Lg2 cluster genes (Cst3, Itga4) and the minor Ccr6 -Cxcr3subset is characterized by the expression of Lg3 cluster genes (Ms4a6c, Zbtb32) ( Figure 6B ). These results demonstrate that the segregation of MBCs based on the expression of Ccr6 and Cxcr3 is an accurate representation of the transcriptionally divergent populations identified by scRNA-seq.

We then examined to which extent the Ccr6 + Cxcr3 + , Ccr6 + Cxcr3and Ccr6 -Cxcr3subsets were clonally expanded. Regardless of the subset, we found that more than 60% of MBCs were constituted by single-cell clones, in line with recent observations from the Nussenzweig lab ( Figure 6C ) (Viant et al., 2020) .

Furthermore, of those cells that were clonally expanded, the vast majority formed small clones of 2-4 cells.

Only 6% of MBCs formed largely expanded clones (>4 cells), a phenomenon that seemed to be independent of antigen-binding as similar clonal size distributions were observed in HA/NP-binding and non-binding cells ( Figure 6C ). Despite the limited number of expanded clones, we moved on to evaluate the overlaps among NP and HA-binding MBCs with non-binding cells from the different subsets. Remarkably, we found notable overlaps among NP/HA-binding cells with non-binding cells from the Ccr6 + Cxcr3 + subset; non significant overlaps were detected with Ccr6 + Cxcr3and Ccr6 -Cxcr3subsets ( Figures 6D-6E) . Furthermore, phylogenetic trees based on heavy and light chain nucleotide sequences show that clones comprising NP/HA-specific cells were either entirely composed of antigen-binding cells or contained several non-binding cells; regardless of the situation, these cells exclusively corresponded to the Ccr6 + Cxcr3 + subset ( Figures 6F-6G) . Overall, our results are in line with scenario number (iii).

To further strengthen this notion, we aimed to explore cells expressing influenza-associated BCRs in a larger dataset. To achieve this, we firstly identified common BCR genes used by NP and HA-binding cells across all mice analyzed. We found that a large fraction of NP-binding cells uses IGHVs 9-3 or 9-4 and IGKVs 5-48, 5-37 or 5-43 genes, indicating that the NP-specific BCR repertoire is in part composed of "public" IgHV / IgKV combinations (Extended Figure 6A ). Although we detected common usage of IGHVs 14-2/1-63 and IGKV 4-72 by HA-specific B cells, numbers were not enough to define HA-associated BCRs with high confidence (Extended Figure 6B ). Then, we used VH 9-3/4 and VK 5-48/37/43 variable gene usage to identify putative NP-specific B cells across lungs, lymph nodes and spleen in our large 10x dataset. We detected 376 VH 9-3/4 + VK 5-48/37/43 + cells among the 3559 cells with paired IgH+IgKL sequences. Remarkably, in all organs and mice analyzed, we observed higher numbers of Cxcr3-expressing cells in the putative NP-specific population than in the one expressing alternative BCR gene combinations (Extended Figure 6C) .

Altogether, the simultaneous analysis of antigen-binding, surface marker expression and B cell repertoire at the single cell level revealed that Ccr6 + Cxcr3 + and Ccr6 + Cxcr3populations represent discrete subsets of MBCs with divergent origins. The Cxcr3 + subset is composed of antigen-specific bona fide MBCs that share common progenitors with low-affinity cells. In contrast, the Cxcr3subset is enriched in bystander MBCs, with no apparent specificity for influenza antigens and originating from highly permissive selection mechanisms in germinal centers.

Remarkably, FB5P-seq transcriptomic analysis showed that bystander Cxcr3 -MBCs express higher levels of Fc receptors for IgE and IgM (Fcer2a and Fcmr) than Cxcr3 + bona fide MBCs ( Figure 6B ). We confirmed this observation at the protein level by flow cytometry (Figures 6H-6I ). This led us to investigate if bystander MBCs could bind immune complexes despite their lack of specificity for influenza antigens, a phenomenon that would increase antigen density in the proximity of bonafide MBCs. We found that incubation of lung MBCs with influenza-IgM immune complexes led to significant binding to bystander MBCs ( Figure 6J ). To assess the contribution of this axis on the magnitude of memory responses, we generated mouse chimeras lacking Fcmr specifically on the B cell compartment. Chimeric mice were infected with influenza H1N1 and re-challenged with influenza H3N2 at day 40. We found a profound reduction in the generation of influenza-specific IgA ASCs in Fcmr-deficient mice, providing evidence for a role of the Fcmr axis on MBC responses ( Figure 6K ).

We were interested to find out whether the establishment of discrete subsets of MBCs in the respiratory environment with contrasting antigen specificities is a general feature of humoral responses to airborne pathogens. To address this question, we intranasally infected K18-hACE2 mice, which express the human angiotensin-converting enzyme 2 receptor under the promoter of cytokeratin 18, with 2.10 3 PFU of SARS-CoV-2 (McCray et al., 2007) . We stained lung sections with antibodies against EpCAM and SARS-CoV-2 NP to track the kinetics of infection by confocal microscopy. We detected foci of SARS NP in peribronchial areas as early as 2 days after infection while the infection rapidly spread towards deeper areas of the lung parenchyma by day 5 ( Figure 7A ). Remarkably, we did not detect SARS-NP in lung tissues by day 70 of infection, in clear contrast to what has been reported in human gut biopsies, where SARS NP is detected even after 3 months of COVID-19 symptom onset (Gaebler et al., 2021) . Furthermore, no effective infection was observed in wild type C57BL/6 mice, confirming previous findings that SARS-CoV-2 does not use mouse ACE2 to infect cells ( Figure 7B ) (Zhou et al., 2020) .

Having set up this acute SARS-CoV-2 infection model in K18-hACE2 mice, we proceeded to analyze MBC populations by flow cytometry 70 days after infection . We administered FITC-labelled anti-CD45 antibody intravenously 5 minutes before sacrifice to exclude circulatory B cells. We observed accumulation of class-switched MBCs (CD19 + CD45i.v. -IgD -CD38 + GL-7 -) in both lungs and mediastinal lymph nodes and the persistence of long-lived germinal center reactions (CD38 -GL-7 + ) exclusively in lymph nodes ( Figures 7C and   7D ). MBCs showed extensive class-switching towards IgG subclasses 2b and 2c ( Figures 7C and 7D ).

Remarkably, we distinguished three discrete populations of MBCs across lungs and lymph nodes based on their differential expression of Ccr6 and Cxcr3 receptors ( Figures 7E and 7F ). The Ccr6 + Cxcr3 + cells extensively bound fluorescently labelled SARS-CoV-2 spike protein, indicating that this population represents the bona fide subset enriched in virus-specific cells ( Figures 7G and 7H ). In contrast, the Ccr6 + Cxcr3and Ccr6 -Cxcr3cells did not show substantial binding to spike protein, indicating that these populations represent bystander and innate-like subsets respectively. To be noted, a significant number of lung-resident memory B and T cells was still observed in mice infected with low doses of SARS-CoV-2 virus, even in those with no apparent weight loss (Extended Figure 7) . These results show that asymptomatic animals can still mount lung memory B and T cell responses to SARS-CoV-2.

We finally analyzed the spatial distribution of MBCs in lungs of SARS-CoV-2 infected animals by confocal imaging. As in this case we cannot rely on YFP expression, we stained lung sections with antibodies against B220, IgM and IgG2b to track MBCs. We found that SARS-CoV-2 infection triggers the formation of B cell clusters that accumulate in peribronchial areas ( Figure 7I ). Interestingly, while IgM + cells were restricted to the periphery of B cell clusters, IgG2b + cells were largely confined in the center ( Figure 7J ). Analysis of Ccr6 and Cxcr3 expression in individual IgG2b + cells, revealed that both Ccr6 + Cxcr3 + and Ccr6 + Cxcr3populations were equally distributed inside the B cell clusters ( Figures 7K-7L) .

Altogether, our results show that SARS-CoV-2 infection, as observed with influenza virus, triggers the accumulation of bona fide, bystander and innate-like MBCs in the respiratory niche with marked differences on antigen-specificity, tissue localization and chemokine receptor expression. These results unveil common MBC mechanisms elicited during infection with diverse families of respiratory viruses.

Several studies have shown that the MBC pool is composed of discrete cell subsets that coexist upon immunization and that bear a differential ability to seed germinal center reactions or form antibody-secreting cells upon re-challenge (Weisel and Shlomchik, 2017) . Some research lines demonstrated that MBC fate is associated with antibody isotype expression: while IgM + MBCs are more predisposed to re-enter germinal center reactions, those expressing IgG are more prone to acquire an antibody-secreting phenotype upon re-challenge (Dogan et al., 2009; Kometani et al., 2013; Lutz et al., 2015; Pape et al., 2011) . However, antibody isotype expression do not always draw a clear-cut line, as class-switched cells were also shown to actively remodel their BCR within secondary germinal center reactions (McHeyzer-Williams et al., 2015) . Work from Shlomchik and collaborators showed that subcategorization of MBCs according to the expression of CD80 and PD-L2, independently of antibody isotype, identify cell subsets with distinct developmental kinetics and functions upon rechallenge (Anderson et al., 2007; Weisel et al., 2016; Zuccarino-Catania et al., 2014) . This differential ability to commit to the germinal center or plasma cell program by CD80-high and CD80-low memory subsets is associated with the unequal amount of CD40L help received (Koike et al., 2019) . As most of these studies were performed in the context of protein immunization, it remained unknown whether distinct subsets of MBCs coexist upon resolution of infection. Here, we used unsupervised transcriptomic analysis to unveil the level of MBC heterogeneity in lungs, mediastinal lymph node and spleen upon respiratory influenza virus infection.

Our study revealed that the MBC pool displays previously unrecognized high levels of heterogeneity across secondary lymphoid organs. For instance, the spleen constitutes a niche for at least five subsets of MBCs that cohabitate this organ upon resolution of influenza infection: follicular, transitional, B1-like, marginal zone and age-associated (ABC) MBCs. While the follicular population exhibits certain levels of class-switching, the other subsets are highly enriched in IgM + MBCs. In line with recent studies, these results show that various splenic B cell populations can participate in the development of a memory response (Berry et al., 2020; Krishnamurty et al., 2016; Riedel et al., 2020; Stone et al., 2019) . Future work is required to establish the contribution of each of these splenic subsets to secondary immune responses upon re-challenge. In marked contrast to spleen, draining lymph nodes are devoid of transitional, marginal zone and ABC memory cells, and are enriched in cells that underwent extensive class-switching towards IgG subclasses. Furthermore, long-lived germinal center reactions are extensively observed in mediastinal lymph nodes but less frequently in the spleen. This phenomenon seems to be a general feature of acute viral infections as robust germinal center reactions are found 10 weeks after influenza, SARS-CoV-2 and vesicular stomatitis virus infection (Bachmann et al., 1996) . The differences between spleen and draining lymph nodes concerning tissue-specific The presence of MBCs is not restricted to secondary lymphoid organs. In recent years, independent studies have shown that MBCs can further settle in non-lymphoid tissues upon resolution of the primary immune response (Oh et al., 2019; Trivedi et al., 2019) . For instance, respiratory infection with influenza virus leads to the development of lung-resident MBCs, which persist in the lung mucosa for long periods of time (Allie et al., 2019; Joo et al., 2008; Onodera et al., 2012) . We found that these lung-resident MBCs are not uniformly distributed across the lung parenchyma. Instead, MBCs form clusters in close proximity to lung bronchi, a strategic place that allows the rapid encounter of pathogens upon re-challenge and that ensures a first layer of protection directly at the tissue barrier. The positioning of lung MBCs directly at sites of antigen entry resembles the one observed in lymphoid organs, where they preferentially accumulate in lymph node interfollicular/subcapsular sinus areas and splenic marginal/follicular zones (Elgueta et al., 2015; Moran et al., 2018) . To be noted, the Ccr6 and Cxcr3 axes are, per se, dispensable for the recruitment/maintenance of MBCs in the lung parenchyma and lymphoid organs (Suan et al., 2017) . Then it is plausible that other chemokine pathways, such as the Cxcr5-Cxcl13 axis, are driving this process (Denton et al., 2019) .

Interestingly, lung-resident MBCs seem to be more cross-protective than their lymphoid tissue counterparts (Adachi et al., 2015; Tamura et al., 1992) . While the basis for this phenomenon remains to be determined, this physiological advantage underscores the potential of harnessing B cells directly at the barrier surfaces to generate broadly protective vaccines.

The aforementioned studies, based the identification of lung-resident MBCs on their ability to bind fluorescently-labelled influenza proteins. Here, we took an unbiased fate mapping approach in mice to track MBCs independently of their antigen specificity and based on their early expression of Aid. By doing so, we were able to identify MBCs with a wide range of antigen specificities, including those with no specificity for viral antigens that were disregarded in previous studies. Through unsupervised scRNA-seq analysis we found that the MBC pool in lungs and draining lymph nodes resemble each other at the level of cluster composition and BCR sequences, indicating that these two compartments are linked in their origin. Furthermore, this analysis unveiled the presence of three discrete clusters of MBCs across lungs and lymph nodes, each of them representing a MBC subset with unique expression patterns of Ccr6 and Cxcr3 receptors. The smallest subset consists of innate-like MBCs, which lack Ccr6 and Cxcr3 expression and exclusively express IgM. We found that these cells are localized at the periphery of lung peribronchial B cell clusters, do not show apparent specificity for viral antigens, and resemble splenic B1-like MBCs based on their gene expression and BCR sequences. These cells may arise from spontaneous germinal center reactions in Peyer's patches or spleen, as a recent study has shown that a large population of IgM + MBCs bearing B1 cell markers, a BCR repertoire skewed towards IgHV6 and specificity for commensal bacteria emerge from there (Le Gallou et al., 2018) .

Besides this minor subset, two large subsets of Ccr6-expressing MBCs further emerge after influenza infection, one of them lacking Cxcr3 expression and the other one characterized by high Cxcr3 surface levels.

We found that both Cxcr3and Cxcr3 + MBC subsets undergo extensive class-switching towards IgG subclasses, share the peribronchial niche in the lung mucosa, and arise from germinal centers, based on their CD40-L dependence and somatic hypermutation levels. These subsets preferentially differentiate into plasma cells, rather than to germinal center cells, and produce similar levels of IgG when challenged ex vivo. Thus, these two transcriptionally distinct memory populations do not segregate cells regarding fate but instead, cells generated through divergent mechanisms. In fact, the Cxcr3 + subset constitutes bona fide MBCs, which are mostly pathogen-specific and are actively recruited during secondary immune responses, while the Cxcr3subset represent bystander MBCs with no evident specificity for pathogen-derived antigens. The following questions are inexorable: how are MBCs from the Cxcr3subset selected in the germinal center and what are they specific for? Elegant work by Kelsoe and collaborators showed that clonal selection is highly permissive in response to complex antigens, allowing the presence of B cells within germinal center reactions with a broad range of affinities and even cells with no detectable affinity for native immunogens (Kuraoka et al., 2016) .

While the authors showed that these "less-fit" germinal center B cells showed extensive somatic hypermutation and clonal diversification, it remained unknown whether they could acquire a memory phenotype. Here, we show that these cells not only enter the long-lived memory compartment but also that they express a unique transcriptional program that distinguishes them from bona fide MBCs. Regarding antigen specificity, it seems unlikely that these cells are very-low affinity, as they acquired VH mutations at comparable if not higher rates than bona fide MBCs and do not display clonal overlap with antigen-specific cells. A potential explanation could be that these cells recognize common autoantigens released as a consequence of immunization. Still, the abovementioned "less-fit" germinal center cells induced by complex antigens do not bind to autoimmune nor common microbial antigens (Horns et al., 2020; Kuraoka et al., 2016 ).

An alternative could be that these cells recognize non-native conformations of immunogens, such as cryptic epitopes exposed by degradation or neoepitopes generated by complement fixation. Yet, our in vivo data showing that Cxcr3 -MBCs do not significantly engage into secondary influenza responses, do not go in line with this hypothesis.

Then, how do these cells still make it to the memory compartment? It has been proposed that low-affinity B cells remain in germinal center reactions due to bystander help received from adjacent T follicular helper cells activated by fitter B cells (Wan et al., 2019; Yeh et al., 2018; Zaretsky et al., 2017) . Furthermore, recent work has shown that low affinity cells express high levels of CD40 on the surface, presumably to compensate for insufficient T cell help (Nakagawa et al., 2021) . While these premises could explain the maintenance of low-affinity B cells in germinal center reactions, it seems unlikely that these processes would keep B cells with no apparent specificity for the immunogen. An alternative explanation arises from our RNA-seq data, which revealed that the Cxcr3 -MBC subset expresses high levels of Fcer2a and Fcmr, the Fc receptors for IgE and IgM. It is tempting to speculate that certain non-specific B cells, expressing unusually high levels of Permissive selection seems to be a general strategy of the immune system activated upon pathogen encounter, as we found that SARS-CoV-2 infection also engenders bona fide and bystander MBC subsets with contrasting antigen specificities. Regardless of the mechanism driving the formation of these memory subsets, our results raise the important question of the potential benefit of such phenomenon, as bystander cells can represent up to 50% of the MBC pool generated upon infection. We propose that the presence of high and low-affinity MBCs within the bona fide subset helps the host to overcome future infections with the same pathogen, mutating variants or even different viruses from the same family, as recently observed with flaviviruses (Viant et al., 2020; Wong et al., 2020) . In contrast, the prevalence of bystander MBCs with no detectable specificity for the infecting pathogen could be beneficial to expand the diversity of the initial B cell repertoire while acting as platforms to retain immune complexes in close proximity to bona fide MBCs. We speculate that this phenomenon could operate as a safeguard mechanism to counteract the loss in B cell repertoire diversity observed, for instance, upon ageing (Gibson et al., 2009; Siegrist and Aspinall, 2009 ).

Mice 8-week old wild-type C57BL/6 mice were obtained from Janvier Labs. Aicda-Cre ERT2 mice were obtained from Claude-Agnès Reynaud and Jean Claude Weill, Institut Necker Enfants Malades, France. Rosa26-EYFP, CCR6 -/and K18-hACE2 mice were obtained from Jackson Laboratories, USA. μMT mice were obtained from Stéphane Mancini, Centre de Recherche en Cancérologie de Marseille, France. CXCR3 -/and Fcmr -/bone marrow were obtained from Jacqueline Marvel, Centre International de Recherche en Infectiologie, France and Tak Mak, University of Toronto, Canada, respectively. Aicda-Cre ERT2 mice were further crossed with Rosa26-EYFP and CCR6 -/mice.

For the generation of mixed bone marrow chimeras, μMT mice of 6-8 weeks of age were irradiated with 2 doses of 4.75 Gy, 4 hours apart. One day later, bone marrow cells were injected i.v. in recipient animals (1x10 6 cells in total). Experimental animals were kept on water with Bactrim for 3 days prior and 3 weeks post irradiation treatment. Chimeras were used after 8 weeks of reconstitution.

Mice were bred and maintained at the animal facilities of the Centre d'Immunologie de Marseille Luminy and Centre d'Immunophénomique. Up to five mice per cage were housed under a standard 12 hr light/dark cycle, with room temperature at 22℃ (19℃-23℃ change). They were fed with autoclaved standard pellet chow and reverse osmosis water. All cages contained 5 mm of aspen chip and tissue wipes for bedding and a mouse house for environmental enrichment. Mice were used at the age of 8 to 12 weeks and littermates (males or females) were randomly assigned to experimental groups. Generally between 4 to 8 mice were used per experimental group. Experimental procedures were conducted in accordance with French and European guidelines for animal care under the permission number 16708-2018091116493528 following review and approval by the local animal ethics committee in Marseille.

Mice were anesthetized i.p. with Ketamine/Xylazine (100 mg/kg body) and intranasally infected with 5 PFU of splenocytes i.v. and 15μg of CpG ODN-1826 (Invivogen) intranasally in PBS (Onodera et al., 2012) . After 10 days, mice received 10 6 splenic CD4 + T cells and 3.10 3 Ccr6 + Cxcr3or Ccr6 + Cxcr3 + MBCs sorted from lungs of B6 mice infected with Influenza PR8 70 days before. The day after, mice were challenged with PR8 virus, weight was measured daily and euthanized if exhibiting ≥20% loss of initial mass.

The strain BetaCoV/France/IDF0372/2020 (SARS-CoV-2) was supplied by the National Reference Centre for Respiratory Viruses hosted by Institut Pasteur (Paris, France) and headed by Pr. Sylvie van der Werf. The human sample from which strain BetaCoV/France/IDF0372/2020 was isolated has been provided by Dr. X. 

Image segmentation was performed using a specific ImageJ macro based on classical binary watershed to generate a mask on YFP + cells. Selections were corrected manually by overlay masking. Mean fluorescence intensity for the B220, CXCR3 and CCR6 channels as well as the area in each COI (Cell of Interest) was exported. The ROI (Region of interest) was defined manually at the beginning of the macro and exported in order to calculate cell density. The macro exports 4 files: the image in TIF, the COI in zip format (.roi), the mean fluorescence intensity and area for each cell in csv, and the channel legend. A specific software named SAPHIR (Shiny Analytical Plot of Histological Image Results) was developed using R, the code source can be downloaded here: https://github.com/elodiegermani/SAPHIR. This software uses the 4 files exported by the ImageJ macro and allows scatterplot gating (cross, polygon or lasso) to filter and define cell populations interactively with the COI overlaid on the image.

40LB cells were cultured in DMEM supplemented with 10% FCS, penicillin 100u/ml, streptomycin 100µg/ml, sodium pyruvate 1mM and beta-mercaptoethanol 5x10 -5 M as previously described (Nojima et al., 2011) . 40LB cells were irradiated (120Gy) and seeded in 24-well plates at a density of 0.25x10 6 cells/well. The following day, sorted MBCs were added on irradiated feeder cells in RPMI, 10% FCS, penicillin 100u/ml, streptomycin 100µg/ml, sodium pyruvate 1mM and beta-mercaptoethanol 5x10 -5 M. Mouse recombinant IL-21 (PeproTech) was added to co-cultures at 10ng/ml. At indicated time points, cells were analyzed by flow cytometry and supernatant collected for posterior antibody analysis.

To measure influenza-specific antibody-secreting cells, enzyme-linked immunosorbent spot (ELISPOT) multiscreen filtration plates (Millipore) were activated with absolute ethanol, washed with PBS and coated overnight at 4℃ with 1μg/ml of nucleoprotein (Sino Biological) diluted in PBS. Plates were subsequently blocked for 1 hour with complete medium and incubated for 24 hours at 37℃ with serial dilutions of lymph node, lung and spleen single cell suspensions. For lungs, the lymphocyte fraction was previously enriched using 

To measure influenza-specific antibodies, ELISA (enzyme-linked immunosorbent assay) plates were coated overnight at 4℃ with 1μg/ml of nucleoprotein or hemagglutinin (Sino Biological) diluted in PBS. Plates were washed with PBS 0.01% Tween, blocked for 2 hours at room temperature with PBS 2.5% FCS and incubated overnight at 4℃ with serial dilutions of co-culture supernatants. The following day, plates were washed and probed at room temperature for 1 hour with 1μg/ml of biotinylated anti-IgG (Southern Biotech) in PBS 2.5%FCS. Plates were washed and incubated at room temperature for 30 minutes with 1μg/ml Streptavidin-Alkaline Phosphatase (Sigma). Plates were washed and developed with p-NitrophenylPhosphate (Sigma). 405nm absorbance was detected using a SPECTRAmax190 plate reader (Molecular Device).

In a first scRNA-seq experiment (Figures 2 and 4) , single-cell suspensions from spleen, lymph nodes and lungs were prepared as described above. Because enzymatic digestion of tissues at 37°C induced the expression of dissociation-induced genes in some lung MBCs (Extended Figure 2 10x 5' scRNA-seq libraries were prepared according to the manufacturer's instructions with modifications for generating the BCR-seq libraries. Following cDNA amplification, SPRI select beads were used to separate the large cDNA fraction derived from cellular mRNAs (retained on beads) from the HTO-containing fraction (in supernatant). For the cDNA fraction derived from mRNAs, 50ng were used to generate transcriptome library and around 5ng were used for BCR library construction. Gene expression libraries were prepared according to manufacturer's instructions. For BCR libraries, heavy and light chain cDNA were amplified by two rounds of PCR (6 cycles + 8 cycles) using external primers recommended by 10x Genomics, and 800 pg of purified amplified cDNA was tagmented using Nextera XT DNA sample Preparation kit (Illumina) and amplified for 12 cycles using the SI-PCR forward primer (10x Genomics) and a Nextera i7 reverse primer (Illumina). For the HTO-containing fraction, 5ng were used to generate the HTO library. The resulting libraries were pooled and sequenced together on an Illumina NextSeq550 platform, using High Output 75-cycle flow cells, targeting 5×10 4 reads per cell for gene expression, 5x10 3 reads per cell for BCR, 2x10 3 reads per cell for hashtag, in paired-end single-index mode (Read 1: 26 cycles, Read i7: 8 cycles, Read 2: 57 cycles).

Single-cell suspensions from lungs of three previously infected Aid-EYFP mice were prepared as described above with enzymatic digestion, and stained with a panel of antibodies for identifying subsets of antigen-specific MBCs (GL7-PerCP-Cy5.5, HA-PE, Ccr6-PE-Dazzle594, CD38-PE-Cy7, NP-APC, CD19-APC-Cy7, Cxcr3-BV421, Live/Dead Aqua stain). FB5P-seq protocol was performed as previously described (Attaf et al., 2020) . Briefly, single MBCs were FACS sorted on a BD Influx into 96-well PCR plates containing 2µl lysis mix per well. The index-sorting mode was activated to record the different fluorescence intensities of each sorted cell. Immediately after cell sorting, plates containing single cells in lysis mix were frozen on dry ice and stored at -80°C until further processing. For each plate, library preparation consisted in RT with template switching for incorporating well-specific barcodes and UMIs, cDNA amplification with 22

cycles of PCR, pooling of 96 wells into one tube, and 5'-end RNA-seq library preparation using tagmentation-based modified Nextera XT DNA sample Preparation kit (Illumina). Libraries were tagged with a plate-specific i7 index and were pooled for sequencing on an Illumina NextSeq2000 platform, with P2 flow cells, targeting 2.5×10 5 reads per cell in paired-end single-index mode (Read 1: 103 cycles, Read i7: 8 cycles,

Read 2: 16 cycles).

Preprocessing and analysis of data were done through the usage of standard tools and custom R and Python scripts. We notably used R version 3.5 and 3.6, Seurat package version 3 (Stuart et al., 2019) , 10x Genomics

CellRanger version 3, CITE-seq-count version 1.4 (Stoeckius et al., 2018) . Docker and Singularity containers were used to ensure the reproducibility of analyses. All codes and data are available on Github and Zenodo.

Pre-processing of FB5P-seq dataset

We used a custom bioinformatics pipeline to process fastq files and generate single-cell gene expression matrices and BCR sequence files as previously described (Attaf et al., 2020) . Detailed instructions for running the FB5P-seq bioinformatics pipeline can be found at https://github.com/MilpiedLab/FB5P-seq. Quality control was performed to remove poor quality cells. Cells with less than 500 genes detected and genes detected in at least 3 cells were removed. We further excluded bad quality cells expressing more than 3% of mitochondrial genes or less than 10% of ribosomal genes. For each cell, gene expression UMI count values were log-normalized with Seurat NormalizeData with a scale factor of 10,000 (Stuart et al., 2019) .

Index-sorting FCS files were visualized in FlowJo software and compensated parameters values were exported in CSV tables for further processing. For visualization on linear scales in the R programming software, we applied the hyperbolic arcsine transformation on fluorescence parameters (Finak et al., 2010) .

For BCR sequence reconstruction, the FB5P-seq pipeline used Trinity for de novo transcriptome assembly for each cell based on Read1 sequences, then MigMap for filtering the resulting contigs for productive BCR sequences and identifying germline V, D and J genes and CDR3 sequence for each contig. Filtered contigs were aligned to reference constant region sequences using Blastn. The FB5P-seq pipeline also ran the pseudoaligner Kallisto to map each cell's FB5P-seq Read1 sequences on its reconstructed contigs and quantify contig expression. The outputs of the FB5P-seq pipeline were further processed and filtered with custom R scripts. For each cell, reconstructed contigs corresponding to the same V(D)J rearrangement were merged, keeping the largest sequence for further analysis. We discarded contigs with no constant region identified in-frame with the V(D)J rearrangement. In cases where several contigs corresponding to the same BCR chain had passed the above filters, we retained the contig with the highest expression level. BCR metadata from the MigMap and Blastn annotations were appended to the gene expression and index sorting metadata for each cell. Finally, heavy and light chain contig sequences were trimmed to retain only sequences from FR1 to the first 36 nucleotides of FR4 regions, and were exported as fasta files for further analysis of clonotypes and BCR phylogenies.

Pre-processing of 10x 5' datasets Raw fastq files from gene expression libraries were processed using Cell Ranger software, with alignment on the mm10 reference genome. For each experiment, cells with less than 200 genes detected and genes detected in less than 3 cells were removed. We further excluded bad quality cells expressing less than 2,000 UMI, more than 40% mitochondrial genes or less than 10% ribosomal genes. HTO barcodes for sample demultiplexing after hashing were counted using CITE-seq-count and were normalized for each cell using a centered log ratio (CLR) transformation across cells implemented in the Seurat function NormalizeData. Cells were demultiplexed using Seurat MULTIseqDemux function and barcodes assigned as doublets or negative were excluded from further analysis. The resulting filtered UMI count matrices were log-normalized with

Seurat NormalizeData with a scale factor of 10,000.

BCR-seq raw fastq files were processed with the FB5P-seq pipeline (Attaf et al., 2020) Phenotypic group metadata were used as labels to color the different nodes and leaves of the resulting BCR sequence phylogenetic trees.

Analysis of datasets were performed using custom R scripts. Variable genes (n=2000) were identified with Seurat FindVariableFeatures (vst method), BCR coding genes were excluded from the lists of variable genes.

After centering with Seurat ScaleData, principal component analysis was performed on variable genes with Seurat RunPCA, and embedded in two-dimensional UMAP plots with Seurat RunUMAP on 20 principal components. UMAP embeddings colored by sample metadata or clusters were generated by Seurat DimPlot, those colored by single gene expression or module scores were generated by Seurat FeaturePlot, those colored by BCR sequence metadata were generated with ggplot2 ggplot.

Clustering was performed using the FindNeighbors and FindClusters methods of the Seurat package using 30 PC for SNN graph build and Leiden clustering method with sensitivity set to 0.5, 1.3, and 0.5 for the first and second 10x datasets, and the FB5P-seq dataset, respectively.

Marker genes between clusters were identified using the FindAllMarkers method of the Seurat package using 

Clonotypes were defined using the composition of (i) associated V gene full name (ii) associated J gene full name (e.g. for heavy chain IGHV9-3*01/IGHJ4*01/42 or for light chain IGKV5-48*01/IGKJ2*01/33) of both heavy and light chain (e.g. Clonotype 1 = IGHV9-3*01/IGHJ4*01/42<<>>IGKV5-48*01/IGKJ2*01/33). We used Clustal Omega from msa R package (10.1093/bioinformatics/btv494) to evaluate the sequence proximity of clonotypes and verify if full BCR sequences in clonotype were consistent. We observed that distances between sequences within clonotypes were much smaller than distances between clonotypes.

Only cell barcodes found in the transcriptomic data and associated with both light chains and heavy chain information were kept for further analysis. Analysis on shared V genes took into account only the main version of the genes (eg. IGHV9-3*01 was identified to IGHV9-3). Clustal Omega (REF DOI: 10.1093/nar/gkz268) was used to assess the clonotype sequence similarities.

The clonotype overlap heatmap was produced considering the set of clonotypes in each cluster and computing the Szymkiewicz-Simpson coefficient between sets. Hierarchical Clustering was performed using the stats hclust function (version 3.6.3) with euclidean distance and average linkage. Plot was performed with the ggplot2 ggplot function (version 3.3).

Index-sorting flow cytometry data were converted through hyperbolic arcsine transformation (asinh) on fluorescence parameters. A scale factor was applied to each transformation. This scale factor was 20, 10, 100

and 100 for CXCR3, CCR6, HA and NP parameters, respectively. CXCR3 + , CCR6 + , HA + and NP + subsets were defined according to the following respective threshold values on asinh transformed data : 0.5, 1.5, 0.8, 0.5. and Cd55. In panels G to I, bar charts show the quantification of one representative experiment out of three, mean ± s.e.m. Each dot represents one mouse. One-way Anova test: **p<0.01 and ****p<0.0001. (B) Confocal microscopy images of mediastinal lymph node sections from Aid-EYFP mice treated as in Figure   1A . Sections were stained with antibodies against YFP (yellow), B220 (red), GL7 (cyan) and CD138 (green). Bar chart shows the proportion of MBCs residing in the indicated lymph node zones. (C) Confocal microscopy images of spleen sections from Aid-EYFP mice treated as in Figure 1A . Sections were stained with antibodies against YFP (yellow), B220 (red) and either CD138 (green) plus GL7 (cyan) or CD169 (green). CD45 (cyan) was injected i.v. in some mice to visualize the marginal zone. Bar chart shows the proportion of MBCs residing in the indicated spleen zones. (D) Confocal microscopy images of lung sections stained with antibodies against YFP (yellow), B220 (grey), Ccr6 (red) and Cxcr3 (green). (E) Dot plot showing the cell area and B220

fluorescence intensity for detected YFP + surfaces in Figure 1D (left). Dot plot showing Ccr6 and Cxcr3 fluorescence intensity for individual YFP + MBCs (center). X and Y positions of Ccr6 -Cxcr3 -(blue), Ccr6 + Cxcr3 -(red) and Ccr6 + Cxcr3 + (green) MBC subsets laid out in the B220 representation (right). (F) Confocal microscopy images of lung sections from wild type and Ccr6-deficient Aid-EYFP mice treated as in Figure 1A .

Sections were stained with antibodies against YFP (yellow), Epcam (cyan) and B220 (red). Quantification Ccr6 + Cxcr3 + MBC subsets in the CD19 + YFP + CD38 + GL7population in mice treated as in Figure 1A plus/minus administration of blocking anti-CD40L. Bar charts show the quantification of one representative experiment.

Each dot represents one mouse, mean ± s.e.m, t-test. Bar charts show the quantification of one representative experiment out of three, mean ± s.e.m. Two-way Anova test, *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001.

We acknowledge Centre de Calcul Intensif d'Aix-Marseille for granting access to its high performance computing resources. This work was supported by the ATIP-AVENIR young group leader program (CNRS-INSERM), junior researcher award (INSERM), and Marie Sklodowska Curie reintegration fellowship (EU) to M.G.; Fondation pour la Recherche Médicale fellowship to S

Distinct germinal center selection at local sites shapes memory B cell response to viral escape

Psychrophilic proteases dramatically reduce single-cell RNA-seq artifacts: a molecular atlas of kidney development

B cell memory: building two walls of protection against pathogens

The establishment of resident memory B cells in the lung requires local antigen encounter

New markers for murine memory B cells that define mutated and unmutated subsets

FB5P-seq: FACS-Based 5-Prime End Single-Cell RNA-seq for Integrative Analysis of Transcriptome and Antigen Receptor Repertoire in B and T Cells

Induction of long-lived germinal centers associated with persisting antigen after viral infection

BCR-Induced Ca Signals Dynamically Tune Survival, Metabolic Reprogramming, and Proliferation of Naive B Cells

Type I interferon induces CXCL13 to support ectopic germinal center formation

Using Genotype Abundance to Improve Phylogenetic Inference

Multiple layers of B cell memory with different effector functions

CCR6-dependent positioning of memory B cells is essential for their ability to mount a recall response to antigen

Optimizing transformations for automated, high throughput analysis of flow cytometry data

Evolution of antibody immunity to SARS-CoV-2

B-cell diversity decreases in old age and is correlated with poor health status

Broad dispersion and lung localization of virus-specific memory B cells induced by influenza pneumonia

The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets

Repression of the transcription factor Bach2 contributes to predisposition of IgG1 memory B cells toward plasma cell differentiation

Somatically Hypermutated Plasmodium-Specific IgM(+) Memory B Cells Are Rapid, Plastic, Early Responders upon Malaria Rechallenge

Complex Antigens Drive Permissive Clonal Selection in Germinal Centers

Memory B cells

A splenic IgM memory subset with antibacterial specificities is sustained from persistent mucosal responses

Reactivation of IgG-switched memory B cells by BCR-intrinsic signal amplification promotes IgG antibody production

Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus

Class-switched memory B cells remodel BCRs within secondary germinal centers

Restricted Clonality and Limited Germinal Center Reentry Characterize Memory B Cell Reactivation by Boosting

Multiplexed detection of proteins, transcriptomes, clonotypes and CRISPR perturbations in single cells

Memory B cells are reactivated in subcapsular proliferative foci of lymph nodes

Permissive selection followed by affinity-based proliferation of GC light zone B cells dictates cell fate and ensures clonal breadth

In-vitro derived germinal centre B cells differentially generate memory B or plasma cells in vivo

Dissociation of solid tumor tissues with cold active protease for single-cell RNA-seq minimizes conserved collagenase-associated stress responses

Migrant memory B cells secrete luminal antibody in the vagina

Memory B cells in the lung participate in protective humoral immune responses to pulmonary influenza virus reinfection

Different B cell populations mediate early and late memory during an endogenous immune response

Discrete populations of isotype-switched memory B lymphocytes are maintained in murine spleen and bone marrow

B-cell responses to vaccination at the extremes of age

Cell Hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics

T-bet Transcription Factor Promotes Antibody-Secreting Cell Differentiation by Limiting the Inflammatory Effects of IFN-γ on B Cells

Comprehensive Integration of Single-Cell Data

CCR6 Defines Memory B Cell Precursors in Mouse and Human Germinal Centers, Revealing Light-Zone Location and Predominant Low Antigen Affinity

Location, location, location: Tissue resident memory T cells in mice and humans

Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine

Liver Is a Generative Site for the B Cell Response to Ehrlichia muris

Antibody Affinity Shapes the Choice between

Germinal center-dependent and -independent memory B cells produced throughout the immune response

Allergen-specific IgE levels and the ability of IgE-allergen complexes to cross-link determine the extent of CD23-mediated T-cell activation

T cells in bystander and cognate interactions with B cells

Memory B Cells of Mice and Humans

A Temporal Switch in the Germinal Center Determines Differential Output of Memory B and Plasma Cells

Affinity-Restricted Memory B Cells Dominate Recall Responses to Heterologous Flaviviruses

Germinal center entry not selection of B cells is controlled by peptide-MHCII complex density

ICAMs support B cell interactions with T follicular helper cells and promote clonal selection

A pneumonia outbreak associated with a new coronavirus of probable bat origin

CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype

We thank the flow cytometry, imaging (Imagimm), bioinformatics and genomics platforms for technical support and the biological resource unit for the breeding of animals (CIML). We thank Claude-Agnès Reynaud and Jean Claude Weill for providing Aicda-Cre ERT2 mice. We thank Stephane Mancini for providing μMT mice.We thank Jacqueline Marvel for providing Cxcr3 -/bone marrows. We thank Tak Mak for providing Fcmr -/bone marrows. We thank Ronan Le Goffic for providing influenza virus strains. We thank Daisuke Kitamura and Michel Cogné for sharing 40LB cells and respective protocols. We thank Amandine Sansoni, Philippe Hoest, Lena Gelard, Quentin Bardin, and Marie Malissen for performing and facilitating the studies with SARS-CoV-2 in the CIPHE biosafety level 3. We thank Cathleen Lutz and The Jackson Laboratory for providing